All lobbying filings

MGD STRATEGIES LLC

Lobbying for ESOPHAGEAL CANCER ACTION NETWORK (ECAN) · Provide support for esophageal cancer patients and esophageal cancer research

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Aug 7, 2026

Income

$20,000

What the client paid this registrant for the period.

Client based in

Maryland

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Budget/Appropriations

Inclusion of esophageal cancer in the FY 2026 Department of Defense's Peer-Reviewed Cancer Research Program Inclusion of report language in the FY 2026 LHHS Appropriations bill Inclusion of esophageal cancer in the FY 2027 Department of Defense's Peer-Reviewed Cancer Research Program Inclusion of report language in the FY 2027 LHHS Appropriations bill

Health Issues

Support passage of the Clinical Trials Modernization Act (S. 4440/H.R. 3521) Support passage of the Gerald E. Connolly Esophageal Cancer Awareness Act (HR3490; Public Law No. 119-96)

Bills named in this filing 3

S. 4440
Clinical Trial Modernization Act
H.R. 3521
Clinical Trial Modernization Act
H.R. 3490
Gerald E. Connolly Esophageal Cancer Awareness Act of 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.